Findings of a trial with pemafibrate in a contemporary patient population
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
Deepak Bhatt, MD
- ESC Congress 2024
Lp(a) in patients with recent CHD
Prof. Kausik Ray, MBChB, MD, MPhil
- ESC Congress 2024
Predicting 30-year CV outcomes in women
Paul Ridker, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA